Anzeige
Mehr »
Dienstag, 23.06.2026 - Börsentäglich über 12.000 News
SEAS meldet US-Behörden-Compliance und plant neues Kobalt-Projekt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CV SCIENCES Aktie jetzt für 0€ handeln
04.06.CV Sciences, Inc. - 8-K, Current Report2
15.05.Cv Sciences outlines CMS program allowing up to $500 annually in hemp-derived products as it targets positive cash flow in H2 20263
14.05.CV Sciences Reports Q1 2026 Results: Full Earnings Call Transcript2
14.05.CV Sciences GAAP EPS of $0.00, revenue of $3.2M2
14.05.CV Sciences, Inc. Reports First Quarter-End 2026 Financial Results283SAN DIEGO, CA / ACCESS Newswire / May 14, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
13.05.CV Sciences, Inc. To Announce First Quarter 2026 Results On May 14, 2026514SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.04.CV Sciences, Inc. - 8-K, Current Report-
26.03.CV Sciences outlines non-cannabinoid product launches and margin gains as company targets cash flow breakeven through 20261
26.03.CV Sciences, Inc. - 10-K, Annual Report2
26.03.CV Sciences Non-GAAP EPS of $0.00, revenue of $13.79M2
26.03.CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results538SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
24.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026378SAN DIEGO, CA / ACCESS Newswire / March 24, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
10.03.CV Sciences, Inc.: CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth473SAN DIEGO, CA / ACCESS Newswire / March 10, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven,...
► Artikel lesen
26.02.CV Sciences, Inc.: CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness397With 20g of clean protein, 5g of creatine, and LactoSpore probiotics, Empowr supports everyday strength, mental energy and digestive balance without dairy or added sugar. Simple, functional nutrition...
► Artikel lesen
23.12.25CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD704SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
13.11.25CV Sciences, Inc. Reports Third Quarter 2025 Financial Results365SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...
► Artikel lesen
11.11.25CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025456SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing...
► Artikel lesen
27.08.25CV Sciences, Inc.: CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus624Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCESS...
► Artikel lesen
13.08.25CV Sciences, Inc. Reports Second Quarter 2025 Financial Results414SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
08.08.25CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025697SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1